Press release
Musculoskeletal Pain Emerging Pipeline and Marketed Drugs Assessment | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies
Globally, several major pharma and biotech giants are persistently working towards the development of novel treatment therapies that can address Musculoskeletal pain. There are several promising drugs in the pipeline, including MPC-06-ID (Mesoblast), ACP-044 (Acadia Pharmaceutical), and MT-554 (Regeneron/Teva Pharmaceutical), among others.
"Musculoskeletal Pain Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Musculoskeletal Pain Therapeutics Market.
The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).
The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Musculoskeletal Pain Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing therapies in the Musculoskeletal Pain Market.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Musculoskeletal Pain treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Musculoskeletal Pain market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Learn More about the Clinical and Commercial Development Activities in the Musculoskeletal Pain Therapeutics Domain:
https://www.delveinsight.com/report-store/musculoskeletal-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Musculoskeletal Pain Therapeutics Analysis
Musculoskeletal pain (MSP) is the most common cause of disability globally and is frequently managed in primary care. Pain due to musculoskeletal problems of the back, neck, shoulder, knee, and multi-site pain is an increasing cause of diminished quality of life and increased demand for healthcare.
The primary unmet need of the Musculoskeletal Pain treatment market is the dearth of approved novel therapies. To meet the increasing demand for the treatment of Musculoskeletal Pain, companies have shifted their focus towards developing novel therapies with fewer adverse events compared to already available analgesics and NSAIDs.
Request for Sample PDF to Understand More About the Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/report-store/musculoskeletal-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Leading Companies in the Musculoskeletal Pain Therapeutics Market Include:
ACADIA Pharmaceuticals, Aesculap Biologics, Ampio Pharmaceuticals, Amzell, Anika Therapeutics, Antibe Therapeutics, AstraZeneca, Axsome Therapeutics, Biosplice Therapeutics, Braeburn Pharmaceuticals, Camurus, Centrexion Therapeutics, Charleston Laboratories, Egalet Ltd, Elli Lilly and company, Flexion Therapeutics, Kolon TissueGene, MDM S.p.A., Mesoblast, Mitsubishi Tanabe Pharma, Moebius Medical, Nektar Therapeutics, Novartis Pharmaceuticals, Pfizer, Propella Therapeutics, Regeneron Pharmaceuticals, Seikagaku Corporation, Sorrento Therapeutics, Sun Pharma Global FZE, Taisho Pharmaceutical, Taiwan Liposome Company, Techfields Pharma, Teva Pharmaceutical Industries, Tonix Pharmaceuticals, Virios Therapeutics, VivaTech, Xalud Therapeutics, and many others.
Musculoskeletal Pain Emerging and Marketed Drugs Analyzed in the Report Include:
• ACP-044: ACADIA Pharmaceuticals
• Ampion: Ampio Pharmaceuticals
• CAM2038: Braeburn Pharmaceuticals
• CNTX-4975: Centrexion Therapeutics
• Egalet-002: Egalet Ltd
• Fasinumab (REGN475): Regeneron Pharmaceuticals
• MPC-06-ID: Mesoblast
• MT-5547: Regeneron /Teva Pharmaceutical
• NKTR-181: Nektar Therapeutics
• Rexlemestrocel-L/MPC-06-ID : Mesoblast
• Tanezumab: Pfizer/Eli Lilly and Company
• Tizaspray: MDM S.p.A
And Many More
Get an in-depth Assessment of the Emerging Therapies and Key Companies:
https://www.delveinsight.com/sample-request/musculoskeletal-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Musculoskeletal Pain Current Treatment Patterns
4. Musculoskeletal Pain - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Musculoskeletal Pain Late-Stage Products (Phase-III)
7. Musculoskeletal Pain Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Musculoskeletal Pain Discontinued Products
13. Musculoskeletal Pain Product Profiles
14. Musculoskeletal Pain Key Companies
15. Musculoskeletal Pain Key Products
16. Dormant and Discontinued Products
17. Musculoskeletal Pain Unmet Needs
18. Musculoskeletal Pain Future Perspectives
19. Musculoskeletal Pain Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/musculoskeletal-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Musculoskeletal Pain Emerging Pipeline and Marketed Drugs Assessment | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies here
News-ID: 2967175 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Musculoskeletal
Musculoskeletal Diseases Treatment Market 2023-2030
Global Musculoskeletal Diseases Treatment Market to Witness Significant Growth Driven by Rising Disease Prevalence and Technological Advancements:
The global musculoskeletal diseases treatment market is experiencing substantial growth, attributed to the increasing prevalence of musculoskeletal diseases and advancements in treatment technologies. A comprehensive analysis conducted by DataM Intelligence presents insights into the market dynamics, trends, and growth opportunities, forecasting market developments until 2029. The report covers key regions, including the United States,…
Rising Musculoskeletal Conditions propel Global Surgical Retractors Market
Inkwood Research anticipates the Global Surgical Retractors Market to surge with a CAGR of 6.22% during the forecast years, 2022-2030, generating a revenue of $3600.08 million by 2030.
Browse 46 market data Tables and 41 Figures spread over 139 Pages, along with an in-depth analysis of the Global Surgical Retractors Market by Application, Type, End-User, & Geography.
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply…
Musculoskeletal Pain Pipeline Insight, 2020 By DelveInsight
(Albany, US) DelveInsight has launched a new report on Musculoskeletal Pain Pipeline
"Musculoskeletal Pain Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Musculoskeletal Pain market. A detailed picture of the Musculoskeletal Pain pipeline landscape is provided, which includes the disease overview and Musculoskeletal Pain treatment guidelines. The assessment part of the report embraces in-depth Musculoskeletal Pain commercial assessment and clinical…
Musculoskeletal Pains Market Huge Demand by 2025
Global Musculoskeletal Pains Market: Snapshot
Musculoskeletal pain is pain that affects bones, muscles, or the various types of connective tissues that hold the two together, such as tendons and ligaments. This type of pain can occur due to overuse or repetitive use of muscle groups, improper use or accidents such as falls, etc. and can persist for a long time, causing discomfort to the patient. The consistent discomfort caused by musculoskeletal…
Musculoskeletal Diseases Treatment Market: Rising Prevalence of Musculoskeletal …
Musculoskeletal diseases treatment is performed with the help of most flexible diagnostic imaging modalities that has capabilities to characterize a wide range of parameters in the living subject as well as provide an exquisite spatial resolution. This technique has been explored by the numerous market players to achieve remarkable precision through extensive innovation in the product design and features. Various recent technological developments are marked in the evolution of musculoskeletal…
Musculoskeletal Pain Therapeutics - Pipeline Analysis 2018
Musculoskeletal pain is a known consequence of repetitive strain, overuse, and work-related musculoskeletal disorders. These injuries include a variety of disorders that cause pain in muscles, bones, joints, or surrounding structures.
Download the sample report @ https://www.pharmaproff.com/request-sample/1086
This pain can be acute or chronic, diffuse or focal. Low back pain is the most common example of chronic musculoskeletal pain. Other musculoskeletal pain includes tendonitis and tendinosis, myalgia, neuropathies, and stress fractures.…
